Navigation Links
FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
Date:10/16/2009

rome (TLS) is a metabolic complication that can result either spontaneously or following treatment of certain types of rapidly-growing cancers, particularly leukemia or lymphoma. The syndrome develops when a particularly large volume of tumor cells are rapidly destroyed by treatment, releasing their contents - including nucleic acids, which are then eventually catabolized into uric acid - into the bloodstream. Elevated levels of plasma uric acid (hyperuricemia) is a serious condition that can lead to kidney impairment if not controlled. Prevalence of TLS varies among patients with different types of cancer, but occurs more often with malignancies that are particularly sensitive to anti-cancer therapy.

About sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, visit: www.sanofi-aventis.us or www.sanofi-aventis.com.

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes th
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Cervarix, GlaxoSmithKlines Cervical Cancer Vaccine
2. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
3. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
4. FDA Approves New Indication For Mirena(R) to Treat Heavy Menstrual Bleeding in IUD Users
5. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
6. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
7. FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
8. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
9. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
10. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
11. FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2012)... 10, 2012 Cyberonics, Inc. (NASDAQ: ... the treatment and management of epilepsy, today announced it ... Conference on Monday, February 27, 2012, in New York. ... Financial Officer, will speak at 11:00 AM Eastern Time.  ... accessed by clicking on the Investor Relations link on ...
(Date:2/10/2012)... 10, 2012  Viztek, the digital radiology solution ... DR U-Arm at Edison Metuchen Orthopaedic Group (EMOG) ... surgeons and a psychiatrist with onsite x-ray and access ... in the same building. EMOG performs ... previously used two traditional analog x-ray rooms to ...
(Date:2/10/2012)... Children and adolescents with obstructive sleep apnea had ... life after treatment with positive airway pressure (PAP)—a ... stream of air through a mask into the ... when children didn,t fully adhere to the treatment," ... sleep specialist and director of the Sleep Center ...
Breaking Medicine Technology:Sleep Breathing Machine Shows Clear Benefits in Children with Sleep Apnea 2Sleep Breathing Machine Shows Clear Benefits in Children with Sleep Apnea 3Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday November 4 2009 After Close of U S Based Financial Markets 14652 1Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday November 4 2009 After Close of U S Based Financial Markets 14652 2Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 1Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 2Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 3Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 4Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 5Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 6Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress 5861 7NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 1NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 2NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 5857 3
... Amicus Therapeutics (Nasdaq: FOLD ) today announced ... No. 7,501,439, titled "Tartrate Salt of Isofagomine and Methods of ... isofagomine, the active ingredient in the Company,s investigational drug Plicera(TM) ... disease. The patent will expire in 2027. John ...
... reduces abdominal pain and bloating CLEVELAND, March 24 ... Postgraduate Medicine found that a strain of probiotic bacteria, ... abdominal pain and bloating in subjects with irritable bowel ... percent of the U.S. population suffer from IBS, a condition ...
Other Medicine Technology:Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 2Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 3New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 2New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 3New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 4
(Date:2/10/2012)... HealthDay Reporter , , THURSDAY, Feb. 9 (HealthDay ... after using marijuana nearly doubles a driver,s risk of ... The risk is especially high for fatal crashes, ... that of people who drive drunk, Canadian researchers say. ... a crash at a higher level than cannabis [marijuana]," ...
(Date:2/10/2012)... the 2012 Annual Meeting of the American Academy ... 4.5 million Americans are living with a total ... surgeries has more than doubled over the past ... Osteoarthritis continues to be the primary reason for ... data; information from the National Health Interview Survey, ...
(Date:2/9/2012)... (February 10, 2012) In a study to be ... meeting, The Pregnancy Meeting , in Dallas, Texas, researchers ... stem cells into the lateral ventricles of neonatal rats ... donor cells can survive and migrate in the recipient,s ... rat,s brain damage mimic brain injury in infants with ...
(Date:2/9/2012)... In a study to be presented today at the ... , in Dallas, Texas, researchers will report findings that ... for women who deliver or intend to deliver outside ... newborns intended for home births compared to hospital births. ... of Birth: Birth Centers and Home Birth Compared to ...
(Date:2/9/2012)... sleep apnea had substantial improvements in attention, anxiety and ... (PAP)a nighttime therapy in which a machine delivers a ... , "The benefits occurred even when children didn,t ... L. Marcus, M.D., a sleep specialist and director of ... The Sleep Center follows thousands of children and adolescents ...
Breaking Medicine News(10 mins):Health News:Pot Use Could Double Risk of Car Crash, Research Shows 2Health News:Pot Use Could Double Risk of Car Crash, Research Shows 3Health News:Pot Use Could Double Risk of Car Crash, Research Shows 4Health News:4.5 million Americans living with total knee replacement 2Health News:Neurologic improvement detected in rats receiving stem cell transplant 2Health News:Sleep breathing machine shows clear benefits in children with sleep apnea 2
... adults have a family history of end-stage renal disease ... of developing kidney disease// themselves, reports a study in ... ,"A family history of kidney disease is more ... risk of ESRD," comments Dr. William McClellan of Emory ...
... exercise is widely recognized to reduce the risk of ... the biological mechanisms behind the effect of exercise on ... exercise decreases inflammation, which reduces the risk of atherosclerosis ... most cases of heart disease. ,In a ...
... type of stem cells from the lungs of transplant patients ... in adult organs and are not derived from bone marrow, ... able to help with the rejection of donated organs and ... by University of Michigan Health System researchers is significant because ...
... ongoing research tries to find why cancer patients undergoing ... of appetite. //The study is also trying to investigate ... maintain a healthy diet during treatment. ,Researchers ... chemotherapy and radiation therapy on the senses report that ...
... a compound that regulates immune response in the ... allergies, if results from an animal study can ... and Philippe Eigenmann from the University Hospital of ... College Cork bioengineered a strain of Lactococcus lactis ...
... to the parents of Canada’s conjoined twins and to the ... //after days of several tests that the twins are growing ... Krista and Tatiana Hogan came into the world with their ... portray distinct sleep patterns, vision, hearing and responses to touch. ...
Other Medicine News:Health News:Ten Percent of Americans Has A Relative With Kidney Failure 2Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 2Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 3Health News:Special Diets Necessary for Those Undergoing Chemotherapy 2Health News:Lactococcus Strain may Offer End to Food Allergies 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: